Emedastine
Top View
- Division of Vital Statistics, Mortality Data Table Page 1 of 147
- (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
- List Item Opatanol : EPAR
- (Therapeutic Products) Regulations 2015
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Clinical Policy: Emedastine (Emadine) Reference Number: ERX.NPA.87 Effective Date: 09.01.18 Last Review Date: 08.18 Revision Log
- Emadine, INN-Emedastine
- Ophthalmic Compositions Comprising Emedastine and Their Use for Treating Allergic Conjunctivitis
- Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
- Ophthalmics for Allergic Conjunctivitis
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Pharmacy Medical Necessity Guidelines: Anti-Allergy Medications, Ophthalmic Effective: January 12, 2021
- Therapeutic Drug Class
- Pharmaabkommen A1 E
- Therapeutic Class Overview Ophthalmic Antihistamines
- Customs Tariff - Schedule Xxi - 1
- WO 2010/141834 Al
- Harmonized Tariff Schedule of the United States (2006) (Rev